Kemper (KMPR)
(Delayed Data from NYSE)
$60.73 USD
-0.52 (-0.85%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $60.70 -0.03 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$60.73 USD
-0.52 (-0.85%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $60.70 -0.03 (-0.05%) 7:58 PM ET
1-Strong Buy of 5 1
D Value F Growth D Momentum F VGM
Zacks News
Cigna (CI) Assigned Shelf Ratings by Moody's, Outlook Stable
by Zacks Equity Research
Shelf ratings of Cigna assigned by Moody's reflect the company' s robust business profile and wide national presence.
Forget MetLife (MET), Buy These 3 Insurance Stocks Instead
by Zacks Equity Research
MetLife's (MET) declining revenues from low premiums, fees and other revenues, macroeconomic factors, and low return on equity make it an unattractive stock now.
Can Kemper Corporation (KMPR) Run Higher on Strong Earnings Estimate Revisions?
by Zacks Equity Research
Kemper Corporation (KMPR) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
by Zacks Equity Research
Zacks Industry Outlook Highlights: Health Insurance Innovations, Kemper Corporation and CNO Financial Group
U.S. Insurance Stock Outlook - August 2017
by Kalyan Nandy
U.S. insurers don't appear to have attracted special attention of investors amid this gradually improving interest rate environment.
Looking for a Top Momentum Stock? 3 Reasons Why Kemper (KMPR) is a Great Choice
by Zacks Equity Research
Kemper Corporation (KMPR) stock is looking quite impressive now for momentum-oriented investors.
Insurance Stock Q2 Earnings Due on Jul 26: XL, TMK & More
by Zacks Equity Research
Insurers' Q2 results are likely to benefit from core business growth, higher premiums and an improving rate environment. Volatile underwriting due to catastrophe loss might weigh on the upside.
Donegal Group Estimates Catastrophe Loss, Sees Loss in Q2
by Zacks Equity Research
Massive weather-related loss ($20.1 million) and fire losses ($7.6 million) drive Donegal Group (DGICA) (DGICB) toward a disappointment in Q2.
Kemper (KMPR) Estimates $32M to $38M in Q2 Catastrophe Loss
by Zacks Equity Research
Kemper Corporation's (KMPR) high estimated pre-tax catastrophe loss for the second-quarter 2017 will likely upset its underwriting results.
New Strong Sell Stocks for July 13th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Kemper Announces Pricing of $200 Senior Notes, Moody's Rates
by Zacks Equity Research
Kemper Corporation (KMPR) has recently announced the offering of 4.350% $200 million senior notes. Moody's Investor Service -- an affiliate of Moody's Corporation (MCO) -- assigned Baa3 rating with stable outlook to the senior notes.
MGIC Investment (MTG): Time to Add the Stock to Portfolio?
by Zacks Equity Research
Shares of MGIC Investment Corporation (MTG) gained 6.32% since Jan 19 when the insurer the reported better than expected fourth-quarter 2016 earnings. It significantly outperformed the Multi line industry's growth of 2.55%.
Kemper (KMPR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Kemper Corporation (KMPR) reported fourth-quarter 2016 net operating income of 56 cents per share, which surpassed the Zacks Consensus Estimate of 42 cents by 33.3%.
Aflac's Senior Unsecured Notes Get Debt Rating from Moody's
by Zacks Equity Research
Aflac Incorporated (AFL) recently received rating action from Moody's Investors Service, a wing of Moody's Corporation (MCO).
Aon (AON) Acquires Admix, Bolsters Footprint in Brazil
by Zacks Equity Research
Aon Plc (AON) recently announced that it has completed its acquisition of Brazilian benefits brokerage and solutions provider, Admix.
Why You Should Hold onto MGIC Investment (MTG) Stock
by Zacks Equity Research
Shares of MGIC Investment Corporation (MTG) gained 40.11% in the last one year, significantly outperforming the Multi line industry's growth of 23.42%.
Why You Should Retain American International (AIG) Stock
by Zacks Equity Research
On Jan 17, 2017, we issued an updated research report on American International Group, Inc. (AIG).
Radian Group (RDN) on Growth Track: Time to Buy the Stock?
by Zacks Equity Research
Radian Group Inc. (RDN) saw its shares gain 57.26% in the last one year, significantly outperforming the Multi line industry's growth of 24.07%.
Should Prudential Financial (PRU) Stock Be in Your Portfolio?
by Zacks Equity Research
Prudential Financial, Inc. (PRU) saw its shares gain 44.61% over the last one year, significantly outperforming the Multi line industry's growth of 22.33%.
Prudential Financial Unit Rolls Out International Bond Fund
by Zacks Equity Research
Prudential Investments, an affiliate of Prudential Financial, Inc. (PRU), recently introduced Prudential International Bond Fund to extend its multi-sector fixed income fund lineup.
Insurance Stock Outlook - Sept. 2015
by Zacks Equity Research
With glaring dissimilarity in business dynamics, it makes better sense to look at the prospects of these two key segments of the U.S. insurance space separately.
Insurance Stock Outlook - Sept. 2015
by Zacks Equity Research
With glaring dissimilarity in business dynamics, it makes better sense to look at the prospects of these two key segments of the U.S. insurance space separately.